Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

By Brufsky A.   Fontaine-Rothe P.   Berlane K.   Rieker P.   Jiroutek M.   Kaplan I.   Kaufman D.   Kantoff P.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 913-920

Elsevier

Access to resources Recommend Favorite

Combined finasteride and flutamide therapy in men with advanced prostate cancer

By Ornstein D.K.   Rao G.S.   Johnson B.   Charlton E.T.   Andriole G.L.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy

By Barqawi A.B.   Moul J.W.   Ziada A.   Handel L.   Crawford E.D.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 872-876

Elsevier

Access to resources Recommend Favorite

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

By Oh W.K.   Manola J.   Bittmann L.   Brufsky A.   Kaplan I.D.   Smith M.R.   Kaufman D.S.   Kantoff P.W.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Microscopic Polyangiitis Complicated by the Development of Prostate Cancer and Flutamide-induced Hepatitis

By Papaioannides D.   Korantzopoulos P.   Bouropoulos C.   Latsi P.   Fotinou M.   Orphanidou D.  

International Urology and Nephrology, Vol. 37, Iss. 3, 2005-09 ,pp. : 515-520

Springer Publishing Company

Access to resources Recommend Favorite